Clinical Trial Update: Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating hzVSF-v13 for efficacy and safety in patients with COVID-19 pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• hzVSF-v13

Snippet

Sponsor: ImmuneMed, Inc. | Conditions: COVID-19 | Phase 2 | Status: COMPLETED